Forum

Notifications

Clear all

Cabozantinib and Nivolumab in Treating Patients With Advanced, Recurrent or Meta

Available Clinical Trials

1 Posts

1 Users

0 Reactions

1,080 Views

RSS

Charmaine Coimbra

(@motherblogger)

Posts: 14

Active Member

Topic starter

Cabozantinib and Nivolumab in Treating Patients With Advanced, Recurrent or Metastatic Endometrial Cancer

This is an open clinical trial at the Mayo Clinic. Here is the link: https://www.mayo.edu/research/clinical-trials/cls-20440737

Posted : 21/05/2019 3:40 am

Forum Icons: Forum contains no unread posts Forum contains unread posts

Topic Icons: Not Replied Replied Active Hot Sticky Unapproved Solved Private Closed

(VELA) Study of BLU-222 in Advanced Solid Tumors | Identifier: NCT05252416

Clinical trials are currently being offered at the University of Arkansas for Medical Sciences (UAMS). Phase 1/2 Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of BLU-222 as a Single… Read More »
A Phase Ib/II Single Arm Study of Cabozantinib Plus Dostarlimab in Women With Recurrent Gynecologic Carcinosarcoma | Identifier: NCT05559879

Clinical trials are currently being offered at the University of Alabama at Birmingham. Immunotherapy has gained a significant amount of attention recently, but its efficacy as a single agent in… Read More »
Testing the Addition of Trastuzumab or Trastuzumab/Pertuzumab to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma | Identifier: NCT05256225

Clinical trials are currently being offered at Medical University of South Carolina (MUSC) Health Care in Charleston SC. A Phase II/III Study of Paciltaxel/Carboplatin alone, or combined with either Trastuzumab… Read More »